Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Germany, France Call for 2-States

The Munich Group, made up of Egypt, Jordan, Germany, and…
Read more

South Africa’s Biometric Registration Plan

The collection of finger prints and facial biometrics is…
Read more

China Threatens ‘Counterstrike’

After strongly condemning a move made by the US regarding…
Read more